Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics

Nonfiction, Health & Well Being, Medical, Specialties, Toxicology, Medical Science, Pharmacology
Cover of the book Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics by , Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780123948236
Publisher: Elsevier Science Publication: June 27, 2013
Imprint: Academic Press Language: English
Author:
ISBN: 9780123948236
Publisher: Elsevier Science
Publication: June 27, 2013
Imprint: Academic Press
Language: English

Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics is a complete reference devoted to the nonclinical safety assessment of novel biopharmaceuticals, biosimilars, vaccines, cell and gene therapies and blood products. This book compares and contrasts these types of biologics with one another and with small molecule drugs, while incorporating the most current and essential international regulatory documents. Each section discusses a different type of biologic, as well as early characterization strategies, principles of study design, preclinical pharmacokinetics and pharmacodynamics and preclinical assays. An edited book that is authored by leading experts in the field, this comprehensive reference provides critical insights to all researchers involved in early through late stage biologics.

  • Provides in-depth coverage of the process of nonclinical safety assessment and comprehensive reviews of each type of biopharmaceutical
  • Contains the most pertinent international regulatory guidance documents for nonclinical evaluation
  • Covers early de-risking strategies and designs of safety assessment programs for novel biopharmaceuticals and vaccines, as well as follow-on biologics or "biosimilars"
  • A multi-authored book with chapters written by qualified experts in their respective fields
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics is a complete reference devoted to the nonclinical safety assessment of novel biopharmaceuticals, biosimilars, vaccines, cell and gene therapies and blood products. This book compares and contrasts these types of biologics with one another and with small molecule drugs, while incorporating the most current and essential international regulatory documents. Each section discusses a different type of biologic, as well as early characterization strategies, principles of study design, preclinical pharmacokinetics and pharmacodynamics and preclinical assays. An edited book that is authored by leading experts in the field, this comprehensive reference provides critical insights to all researchers involved in early through late stage biologics.

More books from Elsevier Science

Cover of the book Micropatterning in Cell Biology, Part C by
Cover of the book Principles of Engineering Manufacture by
Cover of the book Seismic Waves and Rays in Elastic Media by
Cover of the book Designing SQL Server 2000 Databases by
Cover of the book Recent Advances in Nutrigenetics and Nutrigenomics by
Cover of the book The Climate of the Mediterranean Region by
Cover of the book Freshwater Fishes by
Cover of the book FORTRAN 90 for Scientists and Engineers by
Cover of the book Advances in Microbial Physiology by
Cover of the book Regulatory Functions of the CNS Principles of Motion and Organization by
Cover of the book Agent-Based Spatial Simulation with NetLogo Volume 1 by
Cover of the book The Definitive Guide to ARM® Cortex®-M3 and Cortex®-M4 Processors by
Cover of the book Culture, Health and Illness by
Cover of the book Excellence in the Stacks by
Cover of the book Fe-S Cluster Enzymes Part A by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy